Table 7.
Distribution and Five-Year Total, Annual Average Totala, and Average Annual Age-Adjusted Incidence Ratesb of Brain and Other Central Nervous System Tumors by Major Histology Groupings, Histology, and Behavior, CBTRUS Statistical Report: NPCR and SEER, 2009-2013
| Total | Malignant | Non-Malignant | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Histology | 5-year total | Annual average | % of All Tumors | Median Age | Rate | (95% CI) | 5-year total | Annual average | Rate | (95% CI) | 5-year total | Annual average | Rate | (95% CI) |
| Tumors of Neuroepithelial Tissue | 107,732 | 21,546 | 29.3% | 56.0 | 6.60 | (6.56-6.64) | 100,084 | 20,017 | 6.10 | (6.07-6.14) | 7,648 | 1,530 | 0.50 | (0.49-0.51) |
| Pilocytic astrocytoma | 5,106 | 1,021 | 1.4% | 12.0 | 0.35 | (0.34-0.36) | 5,106 | 1,021 | 0.35 | (0.34-0.36) | -- | -- | -- | -- |
| Diffuse astrocytoma | 8,081 | 1,616 | 2.2% | 48.0 | 0.51 | (0.50-0.52) | 8,080 | 1,616 | 0.51 | (0.50-0.52) | -- | -- | -- | -- |
| Anaplastic astrocytoma | 6,245 | 1,249 | 1.7% | 53.0 | 0.39 | (0.38-0.40) | 6,245 | 1,249 | 0.39 | (0.38-0.40) | -- | -- | -- | -- |
| Unique astrocytoma variants | 1,070 | 214 | 0.3% | 23.0 | 0.07 | (0.07-0.07) | 713 | 143 | 0.05 | (0.04-0.05) | 357 | 71 | 0.02 | (0.02-0.03) |
| Glioblastoma | 54,980 | 10,996 | 14.9% | 64.0 | 3.20 | (3.17-3.22) | 54,980 | 10,996 | 3.20 | (3.17-3.22) | -- | -- | -- | -- |
| Oligodendroglioma | 3,852 | 770 | 1.0% | 43.0 | 0.25 | (0.24-0.26) | 3,852 | 770 | 0.25 | (0.24-0.26) | -- | -- | -- | -- |
| Anaplastic oligodendroglioma | 1,677 | 335 | 0.5% | 50.0 | 0.10 | (0.10-0.11) | 1,676 | 335 | 0.10 | (0.10-0.11) | -- | -- | -- | -- |
| Oligoastrocytic tumors | 3,179 | 636 | 0.9% | 41.0 | 0.20 | (0.20-0.21) | 3,178 | 636 | 0.20 | (0.20-0.21) | -- | -- | -- | -- |
| Ependymal tumors | 6,780 | 1,356 | 1.8% | 44.0 | 0.43 | (0.42-0.44) | 4,124 | 825 | 0.26 | (0.26-0.27) | 2,656 | 531 | 0.17 | (0.16-0.17) |
| Glioma malignant, NOS | 7,221 | 1,444 | 2.0% | 36.0 | 0.47 | (0.46-0.48) | 7,221 | 1,444 | 0.47 | (0.46-0.48) | -- | -- | -- | -- |
| Choroid plexus tumors | 784 | 157 | 0.2% | 20.0 | 0.05 | (0.05-0.06) | 112 | 22 | 0.01 | (0.01-0.01) | 672 | 134 | 0.04 | (0.04-0.05) |
| Other neuroepithelial tumors | 95 | 19 | 0.0% | 32.0 | 0.01 | (0.01-0.01) | 60 | 12 | 0.00 | (0.00-0.01) | 35 | 7 | 0.00 | (0.00-0.00) |
| Neuronal and mixed neuronal-glial tumors | 4,367 | 873 | 1.2% | 27.0 | 0.29 | (0.28-0.29) | 860 | 172 | 0.05 | (0.05-0.06) | 3,507 | 701 | 0.23 | (0.23-0.24) |
| Tumors of the pineal region | 686 | 137 | 0.2% | 34.0 | 0.04 | (0.04-0.05) | 381 | 76 | 0.03 | (0.02-0.03) | 305 | 61 | 0.02 | (0.02-0.02) |
| Embryonal tumors | 3,609 | 722 | 1.0% | 9.0 | 0.25 | (0.24-0.25) | 3,496 | 699 | 0.24 | (0.23-0.25) | 113 | 23 | 0.01 | (0.01-0.01) |
| Tumors of Cranial and Spinal Nerves | 30,384 | 6,077 | 8.3% | 56.0 | 1.83 | (1.80-1.85) | 226 | 45 | 0.01 | (0.01-0.02) | 30,158 | 6,032 | 1.81 | (1.79-1.83) |
| Nerve sheath tumors | 30,360 | 6,072 | 8.2% | 56.0 | 1.82 | (1.80-1.85) | 226 | 45 | 0.01 | (0.01-0.02) | 30,134 | 6,027 | 1.81 | (1.79-1.83) |
| Other tumors of cranial and spinal nerves | 24 | 5 | 0.0% | 54.5 | 0.00 | (0.00-0.00) | -- | -- | -- | -- | 24 | 5 | 0.00 | (0.00-0.00) |
| Tumors of Meninges | 139,205 | 27,841 | 37.8% | 65.0 | 8.30 | (8.26-8.35) | 2,464 | 493 | 0.15 | (0.14-0.15) | 136,741 | 27,348 | 8.16 | (8.11-8.20) |
| Meningioma | 134,835 | 26,967 | 36.6% | 66.0 | 8.03 | (7.99-8.07) | 1,711 | 342 | 0.10 | (0.10-0.11) | 133,124 | 26,625 | 7.93 | (7.89-7.97) |
| Mesenchymal tumors | 1,302 | 260 | 0.4% | 48.0 | 0.08 | (0.08-0.09) | 403 | 81 | 0.03 | (0.02-0.03) | 899 | 180 | 0.06 | (0.05-0.06) |
| Primary melanocytic lesions | 136 | 27 | 0.0% | 58.0 | 0.01 | (0.01-0.01) | 90 | 18 | 0.01 | (0.00-0.01) | 46 | 9 | 0.00 | (0.00-0.00) |
| Other neoplasms related to the meninges | 2,932 | 586 | 0.8% | 49.0 | 0.18 | (0.18-0.19) | 260 | 52 | 0.02 | (0.01-0.02) | 2,672 | 534 | 0.17 | (0.16-0.17) |
| Lymphomas and Hematopoietic Neoplasms | 7,415 | 1,483 | 2.0% | 65.0 | 0.44 | (0.43-0.45) | 7,390 | 1,478 | 0.44 | (0.43-0.45) | 25 | 5 | 0.00 | (0.00-0.00) |
| Lymphoma | 7,160 | 1,432 | 1.9% | 66.0 | 0.43 | (0.42-0.44) | 7,160 | 1,432 | 0.43 | (0.42-0.44) | -- | -- | -- | -- |
| Other hematopoietic neoplasms | 255 | 51 | 0.1% | 50.0 | 0.02 | (0.01-0.02) | 230 | 46 | 0.01 | (0.01-0.02) | 25 | 5 | 0.00 | (0.00-0.00) |
| Germ Cell Tumors and Cysts | 1,469 | 294 | 0.4% | 16.0 | 0.10 | (0.09-0.10) | 997 | 199 | 0.07 | (0.06-0.07) | 472 | 94 | 0.03 | (0.03-0.03) |
| Germ cell tumors, cysts and heterotopias | 1,469 | 294 | 0.4% | 16.0 | 0.10 | (0.09-0.10) | 997 | 199 | 0.07 | (0.06-0.07) | 472 | 94 | 0.03 | (0.03-0.03) |
| Tumors of Sellar Region | 61,597 | 12,319 | 16.7% | 51.0 | 3.85 | (3.82-3.88) | 158 | 32 | 0.01 | (0.01-0.01) | 61,439 | 12,288 | 3.84 | (3.81-3.87) |
| Tumors of the pituitary | 58,666 | 11,733 | 15.9% | 51.0 | 3.66 | (3.63-3.69) | 151 | 30 | 0.01 | (0.01-0.01) | 58,515 | 11,703 | 3.65 | (3.62-3.68) |
| Craniopharyngioma | 2,931 | 586 | 0.8% | 43.0 | 0.19 | (0.18-0.19) | -- | -- | -- | -- | 2,924 | 585 | 0.19 | (0.18-0.19) |
| Unclassified Tumors | 20,315 | 4,063 | 5.5% | 62.0 | 1.24 | (1.22-1.26) | 6,587 | 1,317 | 0.39 | (0.38-0.40) | 13,728 | 2,746 | 0.85 | (0.83-0.86) |
| Hemangioma | 5,869 | 1,174 | 1.6% | 50.0 | 0.37 | (0.36-0.38) | 18 | 4 | 0.00 | (0.00-0.00) | 5,851 | 1,170 | 0.37 | (0.36-0.37) |
| Neoplasm, unspecified | 14,356 | 2,871 | 3.9% | 69.0 | 0.87 | (0.85-0.88) | 6,542 | 1,308 | 0.39 | (0.38-0.40) | 7,814 | 1,563 | 0.48 | (0.47-0.49) |
| All other | 90 | 18 | 0.0% | 58.0 | 0.01 | (0.00-0.01) | 27 | 5 | 0.00 | (0.00-0.00) | 63 | 13 | 0.00 | (0.00-0.00) |
| TOTAL c | 368,117 | 73,623 | 100.0% | 59.0 | 22.36 | (22.29-22.44) | 117,906 | 23,581 | 7.18 | (7.14-7.22) | 250,211 | 50,042 | 15.18 | (15.12-15.25) |
aAnnual average cases are calculated by dividing the five-year total by five.
bRates are per 100,000 and are age-adjusted to the 2000 US standard population.
cRefers to all brain and other CNS tumors including histologies not presented in this table.
- Counts are not presented when fewer than 16 cases were reported in the five year period for the specific histology category. The suppressed cases are included in the counts for totals.
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology and End Results program; CI, confidence interval; NOS, not otherwise specified.